These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16783150)

  • 1. A keratitis rat model for evaluation of anti-Acanthamoeba polyphaga agents.
    Vasseneix C; Gargala G; François A; Hellot MF; Duclos C; Muraine M; Benichou J; Ballet JJ; Brasseur G; Favennec L
    Cornea; 2006 Jun; 25(5):597-602. PubMed ID: 16783150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis.
    Polat ZA; Walochnik J; Obwaller A; Vural A; Dursun A; Arici MK
    Clin Exp Ophthalmol; 2014 Mar; 42(2):151-8. PubMed ID: 23601234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.
    Pérez-Santonja JJ; Kilvington S; Hughes R; Tufail A; Matheson M; Dart JK
    Ophthalmology; 2003 Aug; 110(8):1593-600. PubMed ID: 12917179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful medical treatment of Acanthamoeba keratitis.
    Azuara-Blanco A; Sadiq AS; Hussain M; Lloyd JH; Dua HS
    Int Ophthalmol; 1997-1998; 21(4):223-7. PubMed ID: 9700010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of voriconazole anti-Acanthamoeba polyphaga in vitro activity, rat cornea penetration and efficacy against experimental rat Acanthamoeba keratitis.
    Gueudry J; Le Goff L; Compagnon P; Lefevre S; Colasse E; Aknine C; Duval F; François A; Razakandrainibe R; Ballet JJ; Muraine M; Favennec L
    J Antimicrob Chemother; 2018 Jul; 73(7):1895-1898. PubMed ID: 29596605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of miltefosine for topical treatment of Acanthamoeba keratitis in Syrian hamsters.
    Polat ZA; Obwaller A; Vural A; Walochnik J
    Parasitol Res; 2012 Feb; 110(2):515-20. PubMed ID: 21748351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Acanthamoeba keratitis.
    Seal D
    Expert Rev Anti Infect Ther; 2003 Aug; 1(2):205-8. PubMed ID: 15482114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors associated with the need for surgical treatments in acanthamoeba keratitis.
    Bouheraoua N; Gaujoux T; Goldschmidt P; Chaumeil C; Laroche L; Borderie VM
    Cornea; 2013 Feb; 32(2):130-6. PubMed ID: 23132441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weak cytotoxic activity of miltefosine against clinical isolates of Acanthamoeba spp.
    Mrva M; Garajová M; Lukáč M; Ondriska F
    J Parasitol; 2011 Jun; 97(3):538-40. PubMed ID: 21506779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of propolis in experimental Acanthamoeba keratitis.
    Vural A; Polat ZA; Topalkara A; Toker MI; Erdogan H; Arici MK; Cetin A
    Clin Exp Ophthalmol; 2007 Nov; 35(8):749-54. PubMed ID: 17997780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of Acanthamoeba keratitis by hexamidine.
    Brasseur G; Favennec L; Perrine D; Chenu JP; Brasseur P
    Cornea; 1994 Sep; 13(5):459-62. PubMed ID: 7995072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acanthamoeba keratitis with two species of Acanthamoeba.
    Beattie AM; Slomovic AR; Rootman DS; Hunter WS
    Can J Ophthalmol; 1990 Aug; 25(5):260-2. PubMed ID: 2207874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Good outcome in Acanthamoeba keratitis].
    Reichart-Peter S; Manousaridis K; Dirschmid H; Mennel S
    Ophthalmologe; 2017 Jul; 114(7):653-655. PubMed ID: 27558689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic agents and biocides for ocular infections by free-living amoebae of Acanthamoeba genus.
    Carrijo-Carvalho LC; Sant'ana VP; Foronda AS; de Freitas D; de Souza Carvalho FR
    Surv Ophthalmol; 2017; 62(2):203-218. PubMed ID: 27836717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri.
    Schuster FL; Guglielmo BJ; Visvesvara GS
    J Eukaryot Microbiol; 2006; 53(2):121-6. PubMed ID: 16579814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine.
    Seal D; Hay J; Kirkness C; Morrell A; Booth A; Tullo A; Ridgway A; Armstrong M
    Eye (Lond); 1996; 10 ( Pt 4)():413-21. PubMed ID: 8944089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine.
    Duguid IG; Dart JK; Morlet N; Allan BD; Matheson M; Ficker L; Tuft S
    Ophthalmology; 1997 Oct; 104(10):1587-92. PubMed ID: 9331195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reculture technique: individualizing the treatment of Acanthamoeba keratitis.
    Wysenbeek YS; Blank-Porat D; Harizman N; Wygnanski-Jaffe T; Keller N; Avni I
    Cornea; 2000 Jul; 19(4):464-7. PubMed ID: 10928758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acanthamoeba keratitis in a 5-year-old boy without a history of contact lens usage.
    Demirci G; Ay GM; Karabas LV; Altintas O; Tamer GS; Cağlar Y
    Cornea; 2006 Apr; 25(3):356-8. PubMed ID: 16633040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acanthamoeba keratitis: persistent organisms without inflammation after 1 year of topical chlorhexidine.
    Gooi P; Lee-Wing M; Brownstein S; El-Defrawy S; Jackson WB; Mintsioulis G
    Cornea; 2008 Feb; 27(2):246-8. PubMed ID: 18216589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.